Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_assertion type Assertion NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_head.
- NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_assertion description "[Triple negative breast cancer (TNBC) patients are not likely to benefit from anti-estrogen or anti-HER2 therapy and this phenotype is associated with a more aggressive clinical course and worse clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_provenance.
- NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_assertion evidence source_evidence_literature NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_provenance.
- NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_assertion SIO_000772 21308409 NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_provenance.
- NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_assertion wasDerivedFrom befree-2016 NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_provenance.
- NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_assertion wasGeneratedBy ECO_0000203 NP871331.RAC1h1XVkUZVelA7zTuWgzcQGiZ_Ua_q4Y_d1aRl5CcBY130_provenance.